| (Values in U.S. Thousands) | Jun, 2018 | Mar, 2018 | Dec, 2017 | Sep, 2017 | Jun, 2017 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 0 | 0 | 0 | 0 | 0 |
| Net Income Growth | unch | unch | unch | unch | unch |
Cell Tech International Inc (EFLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Cell Tech International Inc. has been harvesting and distributing Aphanizomenon flos-aquae algae as a nutritional supplement under the trade name Super Blue Green Algae. Cell Tech has distributors who sell its products throughout the states, Puerto Rico, Guam and Canada. Cell Tech has also invested in research and development projects with several major universities including Massachusetts General Hospital, which isaffiliated with Harvard University, Neuroscience Laboratory in New Mexico, Royal Victoria Hospital, and University of Illinois. (PRESS RELEASE)
Fiscal Year End Date: 12/31